Use of a Wearable EEG Headband as a Meditation Device for Women With Newly Diagnosed Breast Cancer: A Randomized Controlled Trial

Denise M. Millstine, Anjali Bhagra, Sarah M. Jenkins, Ivana T. Croghan, Daniela L. Stan, Judy C. Boughey, Minh Doan T. Nguyen, Sandhya Pruthi

Research output: Contribution to journalArticle

Abstract

Background: Breast cancer diagnosis and treatment affect quality of life and stress and are associated with fatigue. Meditation interventions are effective strategies for patients with breast cancer but are often limited by poor access, high cost, substantial time commitment, and poor adherence. In this feasibility study, we investigated the use of a portable, wearable, electroencephalographic device for guided meditation practices by breast cancer patients during the period from breast cancer diagnosis until 3 months after surgical treatment. Methods: We enrolled women (age = 20-75 years) who had received a recent diagnosis of breast cancer and planned to undergo surgical treatment. Participants were randomly assigned to perform guided meditation with the device (intervention group) or receive CD-based stress-reduction education (control group). Surveys were used to measure stress, quality of life, and fatigue at baseline, within 4 days before surgery, up to 14 days after surgery, and at 3 months after surgery. Results: In the intervention group, 15 of 17 participants (88.2%) completed the study; in the control group, 13 of 13 participants completed the study (100%). Participants in both groups had less fatigue and stress and improved quality of life at 2 weeks and 3 months after surgery compared with baseline, but there were no significant intergroup differences at any time point. Conclusion: The use of this wearable electroencephalographic device for meditation is a feasible strategy for patients with breast cancer.

Original languageEnglish (US)
JournalIntegrative Cancer Therapies
Volume18
DOIs
StatePublished - Jan 1 2019

Fingerprint

Meditation
Electroencephalography
Randomized Controlled Trials
Breast Neoplasms
Equipment and Supplies
Fatigue
Quality of Life
Ambulatory Surgical Procedures
Control Groups
Feasibility Studies
Psychological Stress
Therapeutics
Education
Costs and Cost Analysis

Keywords

  • biofeedback
  • breast cancer
  • breast surgery
  • fatigue
  • integrative medicine
  • meditation
  • quality of life

ASJC Scopus subject areas

  • Oncology
  • Complementary and alternative medicine

Cite this

Use of a Wearable EEG Headband as a Meditation Device for Women With Newly Diagnosed Breast Cancer : A Randomized Controlled Trial. / Millstine, Denise M.; Bhagra, Anjali; Jenkins, Sarah M.; Croghan, Ivana T.; Stan, Daniela L.; Boughey, Judy C.; Nguyen, Minh Doan T.; Pruthi, Sandhya.

In: Integrative Cancer Therapies, Vol. 18, 01.01.2019.

Research output: Contribution to journalArticle

@article{6feafc29384e4bf489dcc204a31f2d34,
title = "Use of a Wearable EEG Headband as a Meditation Device for Women With Newly Diagnosed Breast Cancer: A Randomized Controlled Trial",
abstract = "Background: Breast cancer diagnosis and treatment affect quality of life and stress and are associated with fatigue. Meditation interventions are effective strategies for patients with breast cancer but are often limited by poor access, high cost, substantial time commitment, and poor adherence. In this feasibility study, we investigated the use of a portable, wearable, electroencephalographic device for guided meditation practices by breast cancer patients during the period from breast cancer diagnosis until 3 months after surgical treatment. Methods: We enrolled women (age = 20-75 years) who had received a recent diagnosis of breast cancer and planned to undergo surgical treatment. Participants were randomly assigned to perform guided meditation with the device (intervention group) or receive CD-based stress-reduction education (control group). Surveys were used to measure stress, quality of life, and fatigue at baseline, within 4 days before surgery, up to 14 days after surgery, and at 3 months after surgery. Results: In the intervention group, 15 of 17 participants (88.2{\%}) completed the study; in the control group, 13 of 13 participants completed the study (100{\%}). Participants in both groups had less fatigue and stress and improved quality of life at 2 weeks and 3 months after surgery compared with baseline, but there were no significant intergroup differences at any time point. Conclusion: The use of this wearable electroencephalographic device for meditation is a feasible strategy for patients with breast cancer.",
keywords = "biofeedback, breast cancer, breast surgery, fatigue, integrative medicine, meditation, quality of life",
author = "Millstine, {Denise M.} and Anjali Bhagra and Jenkins, {Sarah M.} and Croghan, {Ivana T.} and Stan, {Daniela L.} and Boughey, {Judy C.} and Nguyen, {Minh Doan T.} and Sandhya Pruthi",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1534735419878770",
language = "English (US)",
volume = "18",
journal = "Integrative Cancer Therapies",
issn = "1534-7354",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Use of a Wearable EEG Headband as a Meditation Device for Women With Newly Diagnosed Breast Cancer

T2 - A Randomized Controlled Trial

AU - Millstine, Denise M.

AU - Bhagra, Anjali

AU - Jenkins, Sarah M.

AU - Croghan, Ivana T.

AU - Stan, Daniela L.

AU - Boughey, Judy C.

AU - Nguyen, Minh Doan T.

AU - Pruthi, Sandhya

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Breast cancer diagnosis and treatment affect quality of life and stress and are associated with fatigue. Meditation interventions are effective strategies for patients with breast cancer but are often limited by poor access, high cost, substantial time commitment, and poor adherence. In this feasibility study, we investigated the use of a portable, wearable, electroencephalographic device for guided meditation practices by breast cancer patients during the period from breast cancer diagnosis until 3 months after surgical treatment. Methods: We enrolled women (age = 20-75 years) who had received a recent diagnosis of breast cancer and planned to undergo surgical treatment. Participants were randomly assigned to perform guided meditation with the device (intervention group) or receive CD-based stress-reduction education (control group). Surveys were used to measure stress, quality of life, and fatigue at baseline, within 4 days before surgery, up to 14 days after surgery, and at 3 months after surgery. Results: In the intervention group, 15 of 17 participants (88.2%) completed the study; in the control group, 13 of 13 participants completed the study (100%). Participants in both groups had less fatigue and stress and improved quality of life at 2 weeks and 3 months after surgery compared with baseline, but there were no significant intergroup differences at any time point. Conclusion: The use of this wearable electroencephalographic device for meditation is a feasible strategy for patients with breast cancer.

AB - Background: Breast cancer diagnosis and treatment affect quality of life and stress and are associated with fatigue. Meditation interventions are effective strategies for patients with breast cancer but are often limited by poor access, high cost, substantial time commitment, and poor adherence. In this feasibility study, we investigated the use of a portable, wearable, electroencephalographic device for guided meditation practices by breast cancer patients during the period from breast cancer diagnosis until 3 months after surgical treatment. Methods: We enrolled women (age = 20-75 years) who had received a recent diagnosis of breast cancer and planned to undergo surgical treatment. Participants were randomly assigned to perform guided meditation with the device (intervention group) or receive CD-based stress-reduction education (control group). Surveys were used to measure stress, quality of life, and fatigue at baseline, within 4 days before surgery, up to 14 days after surgery, and at 3 months after surgery. Results: In the intervention group, 15 of 17 participants (88.2%) completed the study; in the control group, 13 of 13 participants completed the study (100%). Participants in both groups had less fatigue and stress and improved quality of life at 2 weeks and 3 months after surgery compared with baseline, but there were no significant intergroup differences at any time point. Conclusion: The use of this wearable electroencephalographic device for meditation is a feasible strategy for patients with breast cancer.

KW - biofeedback

KW - breast cancer

KW - breast surgery

KW - fatigue

KW - integrative medicine

KW - meditation

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=85072745661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072745661&partnerID=8YFLogxK

U2 - 10.1177/1534735419878770

DO - 10.1177/1534735419878770

M3 - Article

C2 - 31566031

AN - SCOPUS:85072745661

VL - 18

JO - Integrative Cancer Therapies

JF - Integrative Cancer Therapies

SN - 1534-7354

ER -